Prior Authorization Denials: How to Appeal

Prior authorization (PA) denials occur when a health insurer determines — before care is delivered — that a requested service, drug, or procedure does not meet its coverage criteria. These denials affect millions of patients annually across commercial, employer-sponsored, and government-administered plans, creating a formal dispute pathway governed by federal statute, state regulation, and plan-specific grievance procedures. This page covers the definition and scope of PA denials, the step-by-step appeal mechanism, the most common scenarios in which denials arise, and the legal and procedural boundaries that govern how far an appeal can travel.

Definition and Scope

A prior authorization denial is a pre-service coverage decision in which an insurer refuses to approve a requested item or service before that item or service is rendered. It is distinct from a post-service claim denial — where care has already been delivered and the insurer refuses payment — and from a concurrent review denial, which occurs while a patient is actively receiving inpatient care. Understanding which category a denial falls into matters because appeal deadlines, urgency rights, and review pathways differ across these three types.

The Affordable Care Act (ACA) established minimum internal and external appeal rights for non-grandfathered health plans sold in the individual and small group markets, codified under 45 CFR Part 147 and implementing regulations issued by the Department of Health and Human Services (HHS). Employer-sponsored plans subject to the Employee Retirement Income Security Act (ERISA) operate under a parallel framework administered by the Department of Labor (DOL), outlined in 29 CFR Part 2560.503-1. Medicare Advantage plans follow prior authorization standards set by the Centers for Medicare & Medicaid Services (CMS) under 42 CFR Part 422.

The scope of PA denial appeals is national, but the rights available depend on the plan type. For a broader orientation to how appeal types are classified, see Types of Insurance Appeals.

How It Works

Appealing a prior authorization denial follows a defined procedural sequence. Plans are required under federal and state law to provide a written denial notice that includes the specific reason for denial, the clinical criteria applied, and instructions for initiating an appeal (45 CFR § 147.136).

The standard appeal process unfolds in three phases:

1. Internal Appeal (Level 1): The enrollee or their provider submits a written request for reconsideration to the insurer. Under ACA-compliant plans, the insurer must decide urgent (expedited) internal appeals within 72 hours and standard internal appeals within 30 days of receiving the request. ERISA-governed plans must resolve pre-service appeals within 15 days (urgent) or 30 days (non-urgent) under 29 CFR § 2560.503-1(f).

2. Second-Level Internal Review (where offered): Some plans offer a voluntary second internal appeal tier. Enrollees may elect this option but are not required to exhaust it before proceeding to external review under ACA rules.

3. External Review: If the internal appeal is denied, enrollees in ACA-compliant plans have the right to an independent review organization (IRO) — a neutral third party accredited under standards maintained by the National Association of Insurance Commissioners (NAIC). Federal external review standards apply in states without an approved external review process. IRO decisions on clinical matters are binding on the insurer under 45 CFR § 147.136(d).

For expedited scenarios — situations where the standard timeline would seriously jeopardize health — see Urgent and Expedited Insurance Appeals for the separate procedural track that applies.

Key documentation required at each phase includes the denial letter, the plan's clinical criteria used to make the determination, the treating provider's letter of medical necessity, relevant clinical records, and any applicable research-based literature supporting the treatment. The Evidence Required for Insurance Appeals page details the evidentiary standards that strengthen a submission.

Common Scenarios

Prior authorization denials concentrate in predictable clinical and administrative categories:

Medical necessity denials are the most frequent. The insurer determines that the requested service does not meet its internal definition of medical necessity, often applying proprietary criteria such as those published by InterQual (McKesson) or Milliman Care Guidelines. These denials are the primary subject of Medical Necessity Appeals.

Formulary exclusions for drugs arise when a prescribed medication is not on the plan's approved drug list, or is on a restricted tier requiring authorization. The FDA's National Drug Code Directory does not determine formulary placement — that is a plan-level decision — which creates a common point of confusion for patients.

Experimental or investigational treatment denials occur when an insurer classifies a requested therapy as not yet proven effective under standard coverage criteria. These carry distinct appeal rights discussed at Experimental Treatment Appeals.

Out-of-network service requests may trigger PA denials when an enrollee seeks authorization for a provider outside the plan's network. Network adequacy standards enforced by state insurance departments and CMS create additional grounds for appeal in some circumstances — covered in detail at Network Adequacy Complaints and Appeals.

Step therapy (fail-first) requirements require patients to try one or more lower-cost alternatives before a preferred treatment is approved. As of 2023, 31 states and the District of Columbia have enacted step therapy override laws that establish criteria under which physicians can request exceptions (National Conference of State Legislatures, Step Therapy State Laws).

Decision Boundaries

Several legal and structural thresholds determine how far a PA denial appeal can proceed and what remedies remain available.

Plan type governs available rights. ERISA-regulated employer plans preempt state insurance law on most benefit-structure issues, meaning state external review mandates may not apply. Enrollees in these plans rely primarily on federal ERISA claims procedures and, after exhaustion, federal court review under ERISA § 502(a). The ERISA Appeals: Employer-Sponsored Plans page maps this distinction in detail.

Government program enrollees — Medicare, Medicaid, and Marketplace plan participants — operate under separate statutory frameworks administered by CMS and state Medicaid agencies respectively. Medicare Advantage PA denials are subject to the organization determination and appeals process under 42 CFR § 422.578, with escalation rights to the Medicare Appeals Council and federal district court at defined claim thresholds.

Timeliness is a hard boundary. Failure to file within the plan's stated appeal window — typically 180 days from the denial notice under ACA rules — can extinguish internal appeal rights. Expedited appeals have a 72-hour response requirement from the insurer, but the enrollee must affirmatively request expedited processing by demonstrating that the standard timeline poses a serious health risk.

Clinical versus administrative denials carry different reversal pathways. A denial based on administrative error (e.g., incorrect procedure code, missing provider attestation) is resolved differently from a clinical medical necessity denial. Administrative errors resolved at the plan level do not typically require IRO involvement. Clinical denials that survive internal review must go to an accredited IRO for binding independent review.

State insurance department jurisdiction applies to fully insured commercial plans — not to self-funded ERISA plans. State regulators can investigate pattern-of-denial complaints and require corrective action, even when they cannot adjudicate individual claims under ERISA preemption. The State Insurance Department Appeals page outlines how to engage state regulators as a parallel track to the plan's internal process.

When all appeal remedies are exhausted without resolution, remaining options include filing a formal complaint with the relevant agency, pursuing insurance arbitration, or initiating litigation — each of which carries its own evidentiary and procedural requirements beyond the scope of the PA appeals framework.

References

• U.S. Department of Health and Human Services — About the ACA
• U.S. Department of Labor — ERISA Overview
• Electronic Code of Federal Regulations — 45 CFR § 147.136 (ACA Internal and External Appeals)
• Electronic Code of Federal Regulations — 29 CFR § 2560.503-1 (ERISA Claims Procedure)
• Centers for Medicare & Medicaid Services — Medicare Advantage Regulations, 42 CFR Part 422
• National Association of Insurance Commissioners (NAIC) — Consumer Resources
• [National Conference